Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma
Abstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Annals of Gastroenterological Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1002/ags3.12286 |
id |
doaj-b46aa1ef547d4309b24d16151f4f3649 |
---|---|
record_format |
Article |
spelling |
doaj-b46aa1ef547d4309b24d16151f4f36492021-05-02T12:22:09ZengWileyAnnals of Gastroenterological Surgery2475-03282019-11-013666767510.1002/ags3.12286Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinomaMasateru Yamamoto0Tsuyoshi Kobayashi1Shintaro Kuroda2Michinori Hamaoka3Sho Okimoto4Naruhiko Honmyo5Megumi Yamaguchi6Hideki Ohdan7Department of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanDepartment of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Science Hiroshima University Hiroshima JapanAbstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A total of 478 patients who underwent initial hepatectomy for HCC from 2009 to 2015 and were diagnosed with pathological HCC were included in this retrospective study. Inflammation‐based markers consisted of the C‐reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio and prognostic index. Univariate and multivariate analyses for overall survival (OS) and disease‐free survival (DFS) using the Cox proportional hazard model were carried out. Kaplan‐Meier analysis and log‐rank test were used for comparison of OS and DFS. To reduce influences of selection bias and confounders for stratifying CAR, clinicopathological characteristics of patients were balanced by propensity score matching. Results Multivariate analysis identified only high CAR (>0.027) as an indicator of poor OS, and high CAR and high GPS (1‐2) as indicators of poor DFS among inflammation‐based markers. After propensity score matching, 124 patients each with low CAR and high CAR were matched. High CAR was correlated with both poor OS and DFS. Conclusion C‐reactive protein to albumin ratio was the most valuable prognostic indicator after hepatectomy for HCC among inflammation‐based markers.https://doi.org/10.1002/ags3.12286C‐reactive protein to albumin ratioGlasgow prognostic scorehepatocellular carcinomalymphocyte to monocyte rationeutrophil to lymphocyte ratio |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Masateru Yamamoto Tsuyoshi Kobayashi Shintaro Kuroda Michinori Hamaoka Sho Okimoto Naruhiko Honmyo Megumi Yamaguchi Hideki Ohdan |
spellingShingle |
Masateru Yamamoto Tsuyoshi Kobayashi Shintaro Kuroda Michinori Hamaoka Sho Okimoto Naruhiko Honmyo Megumi Yamaguchi Hideki Ohdan Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma Annals of Gastroenterological Surgery C‐reactive protein to albumin ratio Glasgow prognostic score hepatocellular carcinoma lymphocyte to monocyte ratio neutrophil to lymphocyte ratio |
author_facet |
Masateru Yamamoto Tsuyoshi Kobayashi Shintaro Kuroda Michinori Hamaoka Sho Okimoto Naruhiko Honmyo Megumi Yamaguchi Hideki Ohdan |
author_sort |
Masateru Yamamoto |
title |
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
title_short |
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
title_full |
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
title_fullStr |
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
title_full_unstemmed |
Verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
title_sort |
verification of inflammation‐based prognostic marker as a prognostic indicator in hepatocellular carcinoma |
publisher |
Wiley |
series |
Annals of Gastroenterological Surgery |
issn |
2475-0328 |
publishDate |
2019-11-01 |
description |
Abstract Aim Although inflammation‐based markers in cancer have been used for prognostic prediction, the most useful marker for hepatocellular carcinoma (HCC) has not been established. We investigated the usefulness of various inflammation‐based markers in HCC patients after hepatectomy. Methods A total of 478 patients who underwent initial hepatectomy for HCC from 2009 to 2015 and were diagnosed with pathological HCC were included in this retrospective study. Inflammation‐based markers consisted of the C‐reactive protein to albumin ratio (CAR), Glasgow prognostic score (GPS), neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio, platelet to lymphocyte ratio and prognostic index. Univariate and multivariate analyses for overall survival (OS) and disease‐free survival (DFS) using the Cox proportional hazard model were carried out. Kaplan‐Meier analysis and log‐rank test were used for comparison of OS and DFS. To reduce influences of selection bias and confounders for stratifying CAR, clinicopathological characteristics of patients were balanced by propensity score matching. Results Multivariate analysis identified only high CAR (>0.027) as an indicator of poor OS, and high CAR and high GPS (1‐2) as indicators of poor DFS among inflammation‐based markers. After propensity score matching, 124 patients each with low CAR and high CAR were matched. High CAR was correlated with both poor OS and DFS. Conclusion C‐reactive protein to albumin ratio was the most valuable prognostic indicator after hepatectomy for HCC among inflammation‐based markers. |
topic |
C‐reactive protein to albumin ratio Glasgow prognostic score hepatocellular carcinoma lymphocyte to monocyte ratio neutrophil to lymphocyte ratio |
url |
https://doi.org/10.1002/ags3.12286 |
work_keys_str_mv |
AT masateruyamamoto verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT tsuyoshikobayashi verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT shintarokuroda verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT michinorihamaoka verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT shookimoto verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT naruhikohonmyo verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT megumiyamaguchi verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma AT hidekiohdan verificationofinflammationbasedprognosticmarkerasaprognosticindicatorinhepatocellularcarcinoma |
_version_ |
1721491545205506048 |